STOCK TITAN
  1. Home
  2. Sec-filings
  3. PRVA
  4. [Form 4] Privia Health Group, Inc. Insider Trading Activity

Director at Privia Health (PRVA) receives 8,463 RSU grant as board compensation

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

KING DAVID P reported acquisition or exercise transactions in this Form 4 filing.

Privia Health Group, Inc. director David P. King reported an equity compensation grant rather than an open-market trade. On May 20, 2026, he received 8,463 restricted stock units under the company’s 2021 Omnibus Incentive Plan at no cash cost. These RSUs will vest on the earlier of the day immediately preceding the company’s 2027 annual meeting of stockholders or the first anniversary of the grant date. Following this award, he holds 50,775 common shares directly, showing this filing reflects routine director compensation in stock-based form.

Positive

  • None.

Negative

  • None.

Insights

Director received routine RSU compensation; no open-market buying or selling.

Director David P. King was granted 8,463 restricted stock units on May 20, 2026 under Privia Health’s 2021 Omnibus Incentive Plan. The grant price is effectively $0.00 because it is a stock-based compensation award, not a market purchase.

The RSUs vest on the earlier of the day before the 2027 annual stockholders’ meeting or one year after grant, aligning compensation with continued service. After this grant, King directly holds 50,775 common shares, indicating a modest, ongoing equity stake rather than a large new speculative position.

Insider KING DAVID P
Role Director
Type Security Shares Price Value
Grant/Award Common Stock, $0.01 par value per share 8,463 $0.00 $0.00
Holdings After Transaction: Common Stock, $0.01 par value per share — 50,775 shares (Direct)
Footnotes (1)
  1. F1. On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.
RSU grant size 8,463 units Restricted stock units granted on May 20, 2026
Grant price $0.0000 per share Equity compensation, not open-market purchase
Post-transaction holdings 50,775 shares Common stock directly held after grant
Vesting trigger Earlier of 2027 meeting or 1-year anniversary RSU vesting condition from grant footnote
restricted stock units financial
"the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2021 Omnibus Incentive Plan financial
"received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan"
annual meeting of stockholders financial
"will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transaction did Privia Health (PRVA) report for David P. King?
Privia Health reported that director David P. King received 8,463 restricted stock units as an equity compensation grant. The award was made under the 2021 Omnibus Incentive Plan and did not involve any open-market buying or selling of Privia Health common shares.

When do David P. King’s new Privia Health (PRVA) RSUs vest?
The 8,463 restricted stock units will vest on the earlier of the day immediately before Privia Health’s 2027 annual meeting of stockholders or the first anniversary of the May 20, 2026 grant. This schedule links King’s stock-based compensation to his continued board service.

How many Privia Health (PRVA) shares does David P. King hold after this Form 4?
After the reported grant, David P. King directly holds 50,775 shares of Privia Health common stock. This figure comes from the Form 4’s post-transaction holdings line, reflecting his equity stake following the 8,463 restricted stock unit award.

Was cash paid for the Privia Health (PRVA) RSU grant to David P. King?
No cash changed hands in this transaction. The Form 4 shows a transaction price per share of $0.0000, indicating a stock-based compensation grant of 8,463 restricted stock units, not a cash purchase of Privia Health shares on the open market.

Is the Privia Health (PRVA) Form 4 a buy or sell signal for investors?
The Form 4 reflects an equity compensation grant, not a discretionary buy or sell. David P. King received 8,463 restricted stock units under a company plan, which is a routine board compensation practice rather than an open-market trade signaling his personal view on the stock.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KING DAVID P
(Last)(First)(Middle)
PRIVIA HEALTH GROUP, INC.
950 N. GLEBE RD., SUITE 700.
(Street)
ARLINGTON VIRGINIA 22203
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Privia Health Group, Inc. [ PRVA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, $0.01 par value per share05/20/2026A8,463(1)A$050,775D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.
Remarks:
/s/ Anita Beth Adams, as attorney-in-fact05/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR